IMS Health: Rx for Sleepy Stock (RX)
IMS Health (RX) came in with a 12% revenue rise in their latest quarter, which was right in line with what was expected. The company is a big player in the Pharmaceutical consulting and services area.
Dividend.com archives (articles more than 30 days old) are only available to Dividend.com Premium subscribers.
Sign up for a Dividend.com Premium account for instant access to article archives, stock ratings on nearly 1,600 dividend-paying stocks, and much more! FREE TRIAL available!
If you are a current Dividend.com Premium subscriber, please click here to log in.
Get FREE Dividend Tips, Updates & MoreWe respect your privacy
- Powerful dividend insights sent every weekday morning
- Gain instant access to actionable investing tips
- Strategically grow your portfolio’s profitability